𝔖 Bobbio Scriptorium
✦   LIBER   ✦

325 POSTER Erlotinib, an EGFR kinase inhibitor, sensitizes mesenchymal-like tumor cells to the actions of OXA-01, a selective non-macrolide inhibitor of mTORC1/mTORC2

✍ Scribed by S. Barr; S. Russo; S. Bhagwat; A. Crew; K. Iwata; D. Epstein; J. Pachter; M. Miglarese


Book ID
119599481
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
70 KB
Volume
6
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.